• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对接受癌症治疗的4至7岁儿童的症状筛查工具(儿童简易症状筛查量表)的土耳其语效度和信度研究。

TURKISH VALIDITY AND RELIABILITY STUDY OF A SYMPTOM SCREENING TOOL (MINI-SSPedi) IN 4-7-YEAR-OLD CHILDREN RECEIVING CANCER TREATMENT.

作者信息

Zengin Hamide, Kudubes Aslı Akdeniz, Gerceker Gülcin Ozalp

机构信息

Department of Pediatric Nursing, Faculty of Health Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.

Department of Pediatric Nursing, Faculty of Health Sciences, Bilecik Seyh Edebali University, Bilecik, Turkey.

出版信息

Acta Clin Croat. 2024 Oct;63(2):340-350. doi: 10.20471/acc.2024.63.02.10.

DOI:10.20471/acc.2024.63.02.10
PMID:40104231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11912864/
Abstract

This research was carried out to adapt the Symptom Screening in Pediatrics Tool for Turkish children with cancer aged 4-7 years, and to evaluate its validity and reliability. This study, which was descriptive and methodological, was conducted on 159 children receiving cancer treatments between June 2021 and December 2021. Data collection tools included a socio-demographic form and the Symptom Screening in Pediatrics Tool for children aged 4-7 years (mini-SSPedi). Data were analyzed using Cronbach's alpha, factor analysis, and item-total score analysis. There were 15 items on the mini-SSPedi, and it had one dimension. The results of the exploratory factor analysis indicated that total factor loading was >0.30 and that the Kaiser-Meyer-Olkin value was 0.831. The confirmatory factor analysis indicated that the fit indices were χ/sd: 1.739 (p=0.000), GFI 0.895, CFI 0.919, TLI 0.897, RMSEA 0.068 and SRMR 0.064. Cronbach's alpha coefficient of the total scale was 0.846. The correlation between the items and total scale score ranged between 0.411 and 0.749. The mini-SSPedi was found to be a valid and reliable scale for the Turkish sample. The mini-SSPedi can contribute to determination of symptom screening in children with cancer aged 4-7 years.

摘要

本研究旨在使《儿科症状筛查工具》适用于4至7岁的土耳其癌症患儿,并评估其有效性和可靠性。本研究为描述性和方法学研究,于2021年6月至2021年12月对159名接受癌症治疗的儿童进行。数据收集工具包括一份社会人口学表格和针对4至7岁儿童的《儿科症状筛查工具》(mini-SSPedi)。使用克朗巴哈系数、因子分析和项目总分分析对数据进行分析。mini-SSPedi有15个项目,且为单维度。探索性因子分析结果表明,总因子载荷>0.30,凯泽-迈耶-奥尔金值为0.831。验证性因子分析表明,拟合指数为χ/sd:1.739(p=0.000),GFI为0.895,CFI为0.919,TLI为0.897,RMSEA为0.068,SRMR为0.064。总量表的克朗巴哈系数为0.846。各项目与总量表得分之间的相关性在0.411至0.749之间。发现mini-SSPedi对土耳其样本而言是一个有效且可靠的量表。mini-SSPedi有助于确定4至7岁癌症患儿的症状筛查情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b5/11912864/a1c81deace7d/acc-63-340-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b5/11912864/a1c81deace7d/acc-63-340-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6b5/11912864/a1c81deace7d/acc-63-340-f1.jpg

相似文献

1
TURKISH VALIDITY AND RELIABILITY STUDY OF A SYMPTOM SCREENING TOOL (MINI-SSPedi) IN 4-7-YEAR-OLD CHILDREN RECEIVING CANCER TREATMENT.针对接受癌症治疗的4至7岁儿童的症状筛查工具(儿童简易症状筛查量表)的土耳其语效度和信度研究。
Acta Clin Croat. 2024 Oct;63(2):340-350. doi: 10.20471/acc.2024.63.02.10.
2
Development of mini-SSPedi for children 4-7 years of age receiving cancer treatments.为接受癌症治疗的 4-7 岁儿童开发 mini-SSPedi。
BMC Cancer. 2019 Jan 8;19(1):32. doi: 10.1186/s12885-018-5210-z.
3
Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments.代理-SSPedi 和 mini-SSPedi 在接受癌症治疗的 2-7 岁儿科患者中的可靠性和有效性。
BMC Cancer. 2022 Jul 4;22(1):730. doi: 10.1186/s12885-022-09814-8.
4
Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.验证《儿科症状筛查代理版工具》在接受癌症治疗的儿童中的适用性。
J Pain Symptom Manage. 2018 Jul;56(1):107-112. doi: 10.1016/j.jpainsymman.2018.03.025. Epub 2018 Apr 6.
5
Adaptation of the Food Literacy Questionnaire for school children to Turkish: validity and reliability study.儿童食物素养问卷的土耳其语适应性改编:信度和效度研究。
Eur J Pediatr. 2023 Jul;182(7):3307-3316. doi: 10.1007/s00431-023-05010-3. Epub 2023 May 11.
6
Validation of co-Symptom Screening in Pediatrics Tool: a novel dyadic approach to symptom screening in pediatric patients receiving cancer treatment.儿科共症状筛查工具的验证:一种针对接受癌症治疗的儿科患者进行症状筛查的新型二元方法。
J Natl Cancer Inst. 2024 Jan 10;116(1):160-166. doi: 10.1093/jnci/djad181.
7
Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.验证《儿科症状筛查工具》在接受癌症治疗的儿童中的应用。
J Natl Cancer Inst. 2018 Jun 1;110(6):661-668. doi: 10.1093/jnci/djx250.
8
Symptom screening in paediatrics tool for screening multiple symptoms in Brazilian patients with cancer: a cross-sectional validation study.用于筛查巴西癌症患者多种症状的儿科症状筛查工具:一项横断面验证研究。
BMJ Open. 2019 Aug 2;9(8):e028149. doi: 10.1136/bmjopen-2018-028149.
9
Psychometric properties of the Turkish Version General Self-Efficacy Scale in children and adolescents with cancer.癌症患儿和青少年土耳其版一般自我效能感量表的心理测量特性。
J Pediatr Nurs. 2024 Jul-Aug;77:21-27. doi: 10.1016/j.pedn.2024.03.001. Epub 2024 Mar 11.
10
Turkish version of the resilience scale for young children: Validity and reliability study.土耳其版儿童弹性量表:信度和效度研究。
J Pediatr Nurs. 2024 Sep-Oct;78:e148-e154. doi: 10.1016/j.pedn.2024.06.030. Epub 2024 Jul 16.

本文引用的文献

1
INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES - A FIVE-YEAR SINGLE CENTER EXPERIENCE.血液系统恶性肿瘤患儿侵袭性真菌感染-五年单中心经验。
Acta Clin Croat. 2022 Dec;61(4):647-654. doi: 10.20471/acc.2022.61.04.11.
2
Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments.代理-SSPedi 和 mini-SSPedi 在接受癌症治疗的 2-7 岁儿科患者中的可靠性和有效性。
BMC Cancer. 2022 Jul 4;22(1):730. doi: 10.1186/s12885-022-09814-8.
3
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.
《全国癌症状况年度报告》第 1 部分:国家癌症统计。
J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669. doi: 10.1093/jnci/djab131.
4
Confirmatory Factor Analysis (CFA), Exploratory Structural Equation Modeling (ESEM), and Set-ESEM: Optimal Balance Between Goodness of Fit and Parsimony.验证性因子分析(CFA)、探索性结构方程建模(ESEM)和集束-探索性结构方程建模(Set-ESEM):拟合优度与简约性之间的最佳平衡。
Multivariate Behav Res. 2020 Jan-Feb;55(1):102-119. doi: 10.1080/00273171.2019.1602503. Epub 2019 Jun 17.
5
Development of mini-SSPedi for children 4-7 years of age receiving cancer treatments.为接受癌症治疗的 4-7 岁儿童开发 mini-SSPedi。
BMC Cancer. 2019 Jan 8;19(1):32. doi: 10.1186/s12885-018-5210-z.
6
Palliative care initiation in pediatric oncology patients: A systematic review.儿科肿瘤患者姑息治疗的启动:系统评价。
Cancer Med. 2019 Jan;8(1):3-12. doi: 10.1002/cam4.1907. Epub 2018 Dec 7.
7
Identifying symptoms using the drawings of 4-7 year olds with cancer.通过4至7岁癌症患儿的画作来识别症状。
Eur J Oncol Nurs. 2018 Oct;36:56-61. doi: 10.1016/j.ejon.2018.08.004. Epub 2018 Aug 23.
8
Best Practices for Developing and Validating Scales for Health, Social, and Behavioral Research: A Primer.健康、社会和行为研究量表开发与验证的最佳实践:入门指南。
Front Public Health. 2018 Jun 11;6:149. doi: 10.3389/fpubh.2018.00149. eCollection 2018.
9
RMSEA, CFI, and TLI in structural equation modeling with ordered categorical data: The story they tell depends on the estimation methods.结构方程模型中有序分类数据的 RMSEA、CFI 和 TLI:他们讲述的故事取决于估计方法。
Behav Res Methods. 2019 Feb;51(1):409-428. doi: 10.3758/s13428-018-1055-2.
10
Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.验证《儿科症状筛查工具》在接受癌症治疗的儿童中的应用。
J Natl Cancer Inst. 2018 Jun 1;110(6):661-668. doi: 10.1093/jnci/djx250.